Exosomes are small vesicles of endocytic origin that are released from a variety of cell types under normal or pathological conditions. Although originally described in the 1980's, these vesicles have recently garnered significant attention for their ability to stimulate innate and adaptive immune responses in vitro. In this proposal we predict that exosomes serve a unique role in host responses to Mycobacterium tuberculosis (Mtb) infection. Our main hypothesis is that infected dendritic cells (DCs) and macrophages respond to Mtb-infection by releasing exosomes rich in Mtb antigens and PAMPs, thereby broadcasting stimulation of both innate and adaptive immune receptors beyond the site of infection to enhance immunity to Mtb. The overall objective of this proposal is to determine the biochemical and functional characteristics of exosomes released in response to Mtb-infection. In particular, we will focus on CD4+ T cell responses to exosomes since they are poorly characterized in infection models and may be important for the containment of Mtb-infection. We predict that exosomes provide two signals to promote the genesis of protective CD4+ T cell responses to Mtb. 1. Antigenic signal: Exosomes either directly present peptide-MHC-II complexes to T cells or transfer peptide-MHC-II complexes to recipient DCs for antigen presentation. 2. TLR signaling: CD4+ T cells express TLR2 and respond to TLR2 agonists with enhanced proliferative and cytokine responses upon TCR stimulation. We therefore propose that Mtb TLR2 ligands contained within exosomes generate a second signal during antigen presentation to amplify TCR activation. To assess this model, will first evaluate the biogenesis, composition, and MHC class II antigen presentation capacities of exosomes released by infected DCs and macrophages (Aims 1 and 2). We will then evaluate the ability of TLR2 agonists in Mtb-exosomes to stimulate TLR2 on T cells and enhance T cell responses to Mtb antigens (Aim 3). These studies will test a highly novel function for exosomes in the co-stimulation of T cells responses via T cell-expressed TLRs and will advance our limited understanding of exosome functions in adaptive immunity to Mtb. These studies may also serve as a foundation for the future development of exosome-based diagnostics and therapeutics.

Public Health Relevance

Mycobacterium tuberculosis (Mtb) is a highly successful pathogen that infects one third of the world's population. It is the causative agent of tuberculosi and one of the leading causes of death from infectious disease. Current strategies for the prevention, diagnosis, and treatment of tuberculosis are inadequate and antibiotic resistance is an emerging problem. In this proposal, we will examine a novel aspect of host immune responses to Mtb that may be lead to the development of new therapeutic or diagnostic tools for TB.

National Institute of Health (NIH)
National Institute of Allergy and Infectious Diseases (NIAID)
Exploratory/Developmental Grants (R21)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1-IDM-A (80))
Program Officer
Jacobs, Gail G
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
Case Western Reserve University
Schools of Medicine
United States
Zip Code
Reba, Scott M; Li, Qing; Onwuzulike, Sophia et al. (2014) TLR2 engagement on CD4(+) T cells enhances effector functions and protective responses to Mycobacterium tuberculosis. Eur J Immunol 44:1410-21